Natixis Emergent Bio Solutions Inc. Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Natixis holds 1,827 shares of EBS stock, worth $16,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,827

Previous 1,827 -0.0%

Holding current value

$16,059

Previous $12,000 25.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.86 - $6.98 $20,967 - $78,685	-11,273 Reduced 86.05%	1,827 $12,000
Q1 2024 May 13, 2024	SELL	$1.5 - $3.41 $41,572 - $94,508	-27,715 Reduced 67.9%	13,100 $33,000
Q4 2023 Feb 13, 2024	SELL	$1.82 - $3.16 $461,755 - $801,729	-253,712 Reduced 86.14%	40,815 $97,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $927,859 - $2.32 Million	292,700 Added 16020.8%	294,527 $1 Million
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $3,410 - $6,129	-464 Reduced 20.25%	1,827 $13,000
Q1 2023 May 12, 2023	BUY	$7.79 - $16.29 $17,846 - $37,320	2,291 New	2,291 $23,000
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $197,259 - $313,874	-7,194 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$36.48 - $52.22 $11,600 - $16,605	-318 Reduced 4.23%	7,194 $295,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $859,204 - $1.43 Million	-25,950 Reduced 77.55%	7,512 $327,000
Q3 2021 Nov 12, 2021	BUY	$50.07 - $66.05 $1.16 Million - $1.53 Million	23,109 Added 223.21%	33,462 $1.68 Million
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $37,928 - $53,908	-670 Reduced 6.08%	10,353 $652,000
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $23,971 - $34,802	278 Added 2.59%	11,023 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $850,681 - $1.2 Million	10,745 New	10,745 $963,000
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $189,529 - $239,609	-5,018 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $171,314 - $202,978	5,018	5,018 $203,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account